NIHR Trauma Management MedTech Co-operative (Trauma MIC)

The Trauma MIC team photographed in 2019

We are one of 11 NIHR MedTech and In Vitro diagnostics Co-Operatives (MICs) across England. Established in 2018, the MICs expedite the development of new medical technologies and in-vitro diagnostic tests for use in the NHS. Over five years, the NIHR will invest £14m across the network. 

Map showing NIHR locations

Our Trauma MIC is based at BHP founder-member University Hospitals Birmingham and is responsible for developing and delivering a programme of work that could improve clinical outcomes and quality of life for patients who have suffered traumatic injuries. Our three distinct but inter-related focus areas are:

The time between a traumatic injury and medical stabilisation is a crucial window for new developments. Improving decision support systems, monitoring, diagnostics and transport will all have major benefits to patients. In critical care, better infection control, management of inflammatory responses, better pain control, novel respiratory support, earlier detection of deterioration and maintenance of muscle mass are all areas where progress can be made.

Following initial stabilisation there is the potential for significant advances in tissue repair, regeneration and reconstruction. These include tissue engineering, the management of burns and acute wounds, and surgical interventions.

Survival following trauma can be the beginning of a long, intensive and demanding journey to recovery. Earlier and more effective rehabilitation will help patients’ recovery. There is potential for development in all areas of rehabilitation, including improved prosthetics, robotics, virtual reality and functional electrical muscle stimulation.

The NIHR Trauma Management MedTech Co-operative will build expertise and capacity in the NHS to support the development of new medical technologies in order to enable improved management of the trauma care pathway from the point of injury through to stabilisation and recovery.